Recently, various executives have taken part in insider trading activity for the stocks of Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Celgene Corporation (NASDAQ:CELG), Cytosorbents Corp (NASDAQ:CTSO), and Amedica Corporation (NASDAQ:AMDA).
Synergy Pharmaceuticals Inc
Director Alan Joslyn divested entire direct stake in Synergy Pharmaceuticals, which amounted to 13,754 common shares. The insider sold the shares for $99,347 in three transactions dated September 11. Joslyn joined the board of directors on October 8, 2009. He is currently the Chief Executive Officer of Edusa Pharmaceuticals, a privately held biotechnology company.
Click Here to see the performance of Synergy Pharmaceuticals insiders.
Director Gilla Kaplan disposed 15,000 Celgene shares (14% of total stake), valued at $1,836,750, on September 10. Kaplan now holds 88,485 of the company’s shares that are valued at $10,852,685. According to TipRanks.com, which measures corporate insiders’ success based on their transactions, Gilla Kaplan has an average return of -5.3% and a 25.0% success rate. Kaplan is ranked #21396 out of 34014 corporate insiders.
Click Here to see the performance of Celgene insiders.
Director Al Kraus unloaded 10,000 Cytosorbents shares (15% of total stake), valued at $72,600, in a transaction dated September 10. The shares were sold via automatic sale program. Kraus now holds 55,746 of the company’s shares that are valued at $379,630.
Click Here to see the performance of Cytosorbents insiders.
Principal Accounting Officer and Vice President of Finance Ty Lombardi purchased 25,000 Amedica shares, valued $10,000 on September 10. After completion of the transaction, Lombardi owns 51,971 shares, worth $21,048.
Click Here to see the performance of Amedica insiders.